ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
India's monstrous second wave of COVID-19 caused most of its over 400,000 fatalities during the pandemic and derailed Prime Minister Narendra Modi's vaccine diplomacy.   © Nikkei montage/Source photo by Getty Images
Asia Insight

India's COVID second wave disrupts vaccine export plans

Asia faces shortage as world's biggest jab producer still battles outbreak at home

KIRAN SHARMA, Nikkei staff writer | India

NEW DELHI -- India's COVID-19 vaccine exports have been at a standstill for three months so far -- with little prospect of their resumption anytime soon -- after a deadly second wave of the virus ravaged the South Asian nation of over 1.3 billion people in April and May.

Global supplies of made-in-India jabs were part of Prime Minister Narendra Modi's vaccine diplomacy for contesting regional and global influence with China. The disastrous resurgence of the pandemic has stalled not only New Delhi's diplomacy, but also the inoculation drives of importing countries in the Asia-Pacific and beyond.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more